Then, serum levels of prostate‐specific antibody (PSA) increase again rapidly, meeting the stage of castration‐resistant prostate cancer (CRPC), which is the leading cause of tumor‐specific death in PCa.11, 12, 13, 14. Here, KLK3 is linked to neoplasm.